Clinical significance of microscopic melanoma metastases in the nonhottest sentinel lymph nodes

JAMA Surgery

Volumn 150, Issue 5, 2015, Pages 465-472

  Luo, Su ^a   Lobo, Alice Z C ^a,b   Tanabe, Kenneth K ^a   Muzikansky, Alona ^a   Durazzo, Tyler ^a   Sober, Arthur ^a   Tsao, Hensin ^a   Cosimi, A Benedict ^a   Lawrence, Donald P ^a   Duncan, Lyn M ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

TECHNETIUM 99M;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER MORTALITY; CANCER SPECIFIC SURVIVAL; CHILD; CONTROLLED STUDY; CUTANEOUS MELANOMA; FALSE NEGATIVE RESULT; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MALE; MALIGNANT LENTIGO; MITOGENICITY; NEUROTROPISM; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RADIOACTIVITY; RETROSPECTIVE STUDY; SENTINEL LYMPH NODE METASTASIS; TUMOR ASSOCIATED LEUKOCYTE; TUMOR INVASION; DISEASE COURSE; INCIDENCE; LYMPH NODE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MELANOMA; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SECONDARY; SENTINEL LYMPH NODE BIOPSY; UNITED STATES; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MASSACHUSETTS; MELANOMA; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SENTINEL LYMPH NODE BIOPSY; YOUNG ADULT;

EID: 84929688728     PISSN: 21686254     EISSN: 21686262     Source Type: Journal    
DOI: 10.1001/jamasurg.2014.3843     Document Type: Article

References (39)

1. Thompson JF. The value of sentinel node biopsy in patients with primary cutaneous melanoma. Dermatol Surg. 2008;34(4):550-554.
2. Scheri RP, Essner R, Turner RR, Ye X, Morton DL. Isolated tumor cells in the sentinel node affect long-term prognosis of patients with melanoma. Ann Surg Oncol. 2007;14(10):2861-2866.
3. Murali R, Thompson JF, Shaw HM, Scolyer RA. The prognostic significance of isolated immunohistochemically positive cells in sentinel lymph nodes of melanoma patients. Am J Surg Pathol. 2008;32(7):1106-1107.
4. Gershenwald JE, Thompson W, Mansfield PF, et al. Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients. J Clin Oncol. 1999;17(3):976-983.
5. Mays MP, Martin RC, Burton A, et al. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy? Cancer. 2010;116(6):1535-1544.
6. Messina JL, Sondak VK. Refining the criteria for sentinel lymph node biopsy in patients with thinner melanoma: a roadmap for the future. Cancer. 2010;116(6):1403-1405.
7. Gershenwald JE, Ross MI. Sentinel-lymph-node biopsy for cutaneous melanoma. N Engl J Med. 2011;364(18):1738-1745.
8. Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27(36):6199-6206.
9. Wargo JA, Tanabe K. Surgical management of melanoma. Hematol Oncol Clin North Am. 2009;23(3):565-581, x.
10. Bilimoria KY, Balch CM, Bentrem DJ, et al. Complete lymph node dissection for sentinel node-positive melanoma: assessment of practice patterns in the United States. Ann Surg Oncol. 2008;15(6):1566-1576.
11. Stebbins WG, Garibyan L, Sober AJ. Sentinel lymph node biopsy and melanoma: 2010 update, part I. J Am Acad Dermatol. 2010;62(5):723-734; quiz 735-736.
12. Thompson JF, Uren RF. Lymphatic mapping in management of patients with primary cutaneous melanoma. Lancet Oncol. 2005;6(11):877-885.
13. Essner R, Bostick PJ, Glass EC, et al. Standardized probe-directed sentinel node dissection in melanoma. Surgery. 2000;127(1):26-31.
14. Prieto VG, Clark SH. Processing of sentinel lymph nodes for detection of metastatic melanoma. Ann Diagn Pathol. 2002;6(4):257-264.
15. Shidham VB. Evaluation of sentinel lymph nodes for melanoma metastases by pathologists. Clin Plast Surg. 2010;37(1):101-112.
16. Dekker J, Duncan LM. Lack of standards for the detection of melanoma in sentinel lymph nodes: a survey and recommendations. Arch Pathol Lab Med. 2013;137(11):1603-1609.
17. Wen DR, Cochran AJ, Huang RR, Itakura E, Binder S. Clinically relevant information from sentinel lymph node biopsies of melanoma patients. J Surg Oncol. 2011;104(4):369-378.
18. Yu LL, Flotte TJ, Tanabe KK, et al. Detection of microscopic melanoma metastases in sentinel lymph nodes. Cancer. 1999;86(4):617-627.
19. Lobo AZ, Tanabe KK, Luo S, et al. The distribution of microscopic melanoma metastases in sentinel lymph nodes: implications for pathology protocols. Am J Surg Pathol. 2012;36(12):1841-1848.
20. Morton DL, Wen D-R, Wong JH, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg. 1992;127(4):392-399.
21. Morton DL, Thompson JF, Essner R, et al; Multicenter Selective Lymphadenectomy Trial Group. Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Ann Surg. 1999;230(4):453-463.
22. Morton DL, Cochran AJ, Thompson JF, et al; Multicenter Selective Lymphadenectomy Trial Group. Sentinel node biopsy for early-stage melanoma: accuracy and morbidity in MSLT-I: an international multicenter trial. Ann Surg. 2005;242(3):302-311.
23. Morton DL, Wanek L, Nizze JA, Elashoff RM, Wong JH. Improved long-term survival after lymphadenectomy of melanoma metastatic to regional nodes. Analysis of prognostic factors in 1134 patients from the John Wayne Cancer Clinic. Ann Surg. 1991;214(4):491-499.
24. Balch CM, Cascinelli N. Sentinel-node biopsy in melanoma. N Engl J Med. 2006;355(13):1370-1371.
25. Morton DL, Thompson JF, Cochran AJ, et al; MSLT Group. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med. 2006;355(13):1307-1317.
26. Wong SL, Balch CM, Hurley P, et al; American Society of Clinical Oncology; Society of Surgical Oncology. Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline. J Clin Oncol. 2012;30(23):2912-2918.
27. Gershenwald JE, Andtbacka RH, Prieto VG, et al. Microscopic tumor burden in sentinel lymph nodes predicts synchronous nonsentinel lymph node involvement in patients with melanoma. J Clin Oncol. 2008;26(26):4296-4303.
28. Berk DR, Johnson DL, Uzieblo A, Kiernan M, Swetter SM. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004. Arch Dermatol. 2005;141(8):1016-1022.
29. Faries MB, Thompson JF, Cochran A, et al; MSLT Cooperative Group. The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: results of the Multicenter Selective Lymphadenectomy Trial (I). Ann Surg Oncol. 2010;17(12):3324-3329.
30. Saltman BE, Ganly I, Patel SG, et al. Prognostic implication of sentinel lymph node biopsy in cutaneous head and neck melanoma. Head Neck. 2010;32(12):1686-1692.
31. Jones EL, Jones TS, Pearlman NW, et al. Long-term follow-up and survival of patients following a recurrence of melanoma after a negative sentinel lymph node biopsy result. JAMA Surg. 2013;148(5):456-461.
32. Evans HL, Krag DN, Teates CD, et al. Lymphoscintigraphy and sentinel node biopsy accurately stage melanoma in patients presenting after wide local excision. Ann Surg Oncol. 2003;10(4):416-425.
33. Morton DL, Hoon DS, Cochran AJ, et al. Lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: therapeutic utility and implications of nodal microanatomy and molecular staging for improving the accuracy of detection of nodal micrometastases. Ann Surg. 2003;238(4):538-549.
34. Cochran AJ, Balda BR, Starz H, et al. The Augsburg Consensus: techniques of lymphatic mapping, sentinel lymphadenectomy, and completion lymphadenectomy in cutaneous malignancies. Cancer. 2000;89(2):236-241.
35. Murali R, Thompson JF, Scolyer RA. Can histologic parameters of melanoma metastases in sentinel lymph nodes reliably select patients who can be safely spared completion lymph node dissection? Ann Surg. 2010;251(6):1188-1189.
36. Leung AM, Morton DL, Ozao-Choy J, et al. Staging of regional lymph nodes in melanoma: a case for including nonsentinel lymph node positivity in the American Joint Committee on Cancer staging system. JAMA Surg. 2013;148(9):879-884.
37. Zogakis TG, Essner R, Wang HJ, et al. Melanoma recurrence patterns after negative sentinel lymphadenectomy. Arch Surg. 2005;140(9):865-871; discussion 871-872.
38. Wright BE, Scheri RP, Ye X, et al. Importance of sentinel lymph node biopsy in patients with thin melanoma. Arch Surg. 2008;143(9):892-899.
39. Andtbacka RH, Gershenwald JE. Role of sentinel lymph node biopsy in patients with thin melanoma. J Natl Compr Canc Netw. 2009;7(3):308-317.